Font Size: a A A
Keyword [Multidrug resistant Acinetobacter baumannii]
Result: 21 - 40 | Page: 2 of 3
21. Characterization And Genomic Analysis Of Phage PAb-3, A Novel T4-like Bacteriophage Targets To Multidrug Resistant Acinetobacter Baumannii
22. Study On The Resistance Mechanisms To Tigecycline In Multidrug-resistant Acinetobacter Baumannii
23. Clinical Characteristics, Risk Factors For Occurrence And Prognosis Analysis For Multidrug-resistant Acinetobacter Baumannii In A Tertiary Care Hospital From 2010 To 2012
24. The Study Of Tigecycline Combination Therapy For Prevention Multidrug-resistant Acinetobacter Baumannii Resistance In Vitro PK/PD Model
25. Antibacterial Mechanism Of Silver Nanoparticles On Multidrug-Resistant Acinetobacter Baumannii
26. The Analysis Of Prognostic Factors Of Severe Pneumonia Caused By Multidrug Resistant Acinetobacter Baumannii
27. Rapid Detection 4 Resistance Genes In Multidrug-resistant Acinetobacter Baumannii Using Multiplex PCR And High Resolution Melting Assay
28. Establishment Of An Infection Model Using Caenorhabditis Elegans-multidrug Resistant Acinetobacter Baumannii
29. Mechanism Of 35 Strains MDR-AB Integron And FIC Of Minocycline Combined With 10 Antibiotics Of Study
30. Resistance Mechanisms Agaisnt Polymyxin B In Multidrug-resistant Acinetobacter Baumannii
31. The Genome Expression Characteristics Of Multidrug Resistant Acinetobacter Baumannii Biofilm And Its Effects On The Bacterial Pathogenicity
32. The Biological Characteristics And Eravacycline Resistant Mechanisms In Multidrug-resistant Acinetobacter Baumannii
33. Catechol Cross-linked Antimicrobial Peptide Hydrogels Prevent Multidrug-resistant Acinetobacter Baumannii And MRSA Infection In Burn Wound And Accelerate Wound Healing
34. Epidemiological Characteristics Of Multidrug-resistant Acinetobacter Baumannii In A Teaching Hospital In 2016
35. Investigation On Molecular Epidemiology Of Multidrug-Resistant Acinetobacter Baumannii
36. Control Of Multidrug-Resistant Acinetobacter Baumannii: A Biocidal Efficacy Study Of Low-Temperature Air Plasma
37. Clinical Characteristics And Independent Risk Factor Analysis Of Multidrug Resistant Acinetobacter Baumannii In Hospital
38. Risk Factors And Drug Resistance Of Multidrug-resistant Acinetobacter Baumannii Blood Stream Infections In Intensive Care Unit Patients
39. In Vivo And In Vitro Efficacy Of Cefoperazone Sulbactam-based Combination Therapy For MDR-AB And Clinical Evaluation
40. Molecular Epidemiological Study Of Clinically Isolated Multidrug-resistant Acinetobacter Baumannii And A Case Of Whole Genome Sequencing Analysis Of Acinetobacter Pittii
  <<First  <Prev  Next>  Last>>  Jump to